Clinical trial
Effect of Valsartan on Carotid Artery Disease
NCT00208767 · Emory University, Other · Completed
Key facts
| NCT number | NCT00208767 |
|---|---|
| Title | Effect of Valsartan on Carotid Artery Disease |
| Official title | Effect of Valsartan on Endothelial Function, Oxidative Stress, Carotid Atherosclerosis, and Endothelial Progenitor Cells (EFFERVESCENT) |
| Lead sponsor | Emory University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carotid Artery Diseases, Atherosclerosis |
| Intervention type | Drug |
| Interventions | Valsartan, Placebo |
| Enrollment | 120 |
| Start date | Feb 1, 2005 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Sep 21, 2005 |
| Last update posted | Dec 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: